ArticleTranslational lung cancer research2022

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.

Kohei Kushiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.